Abstract

Transcutaneous auricular vagus nerve stimulation (taVNS) has shown promise as a non-invasive alternative to vagus nerve stimulation (VNS) with implantable devices, which has been used to treat drug-resistant epilepsy and treatment-resistant depression. Prior work has used functional MRI to investigate the brain response to taVNS, and more recent work has also demonstrated potential therapeutic effects of high-frequency sub-threshold taVNS in rheumatoid arthritis. However, no studies to date have measured the effects of high-frequency sub-threshold taVNS on cerebral blood flow (CBF). The objective of this study was to determine whether high-frequency (20 kHz) sub-threshold taVNS induces significant changes in CBF, a promising metric for the assessment of the sustained effects of taVNS. Arterial spin labeling (ASL) MRI scans were performed on 20 healthy subjects in a single-blind placebo-controlled repeated measures experimental design. The ASL scans were performed before and after 15 min of either sub-threshold taVNS treatment or a sham control. taVNS induced significant changes in CBF in the superior posterior cerebellum that were largely localized to bilateral Crus I and Crus II. Post hoc analyses showed that the changes were driven by a treatment-related decrease in CBF. Fifteen minutes of high-frequency sub-threshold taVNS can induce sustained CBF decreases in the bilateral posterior cerebellum in a cohort of healthy subjects. This study lays the foundation for future studies in clinical populations, and also supports the use of ASL measures of CBF for the assessment of the sustained effects of taVNS.

Highlights

  • Transcutaneous auricular vagus nerve stimulation has shown promise as a non-invasive alternative to vagus nerve stimulation (VNS) with implantable devices, which has been used to treat drug-resistant epilepsy and treatment-resistant depression

  • Our findings reveal a significant bilateral decrease in cerebellar cerebral blood flow (CBF) as a result of 15 min of sub-threshold Transcutaneous auricular vagus nerve stimulation (taVNS), reflecting physiological changes that persisted for many minutes after the treatment

  • The prior findings are limited to characterizing the acute cerebellar CBF response to VNS, while the current findings offer evidence of a sustained decrease in cerebellar CBF in reponse to taVNS

Read more

Summary

Introduction

Transcutaneous auricular vagus nerve stimulation (taVNS) has shown promise as a non-invasive alternative to vagus nerve stimulation (VNS) with implantable devices, which has been used to treat drug-resistant epilepsy and treatment-resistant depression. Measures of cerebral blood flow (CBF), a well-defined physiological quantity, can be used to characterize changes in brain physiology occurring over periods ranging from seconds to y­ ears[18], and constitute a promising metric for the assessment of the sustained effects of VNS. In prior work, both SPECT and PET have been used to characterize the CBF response to VNS applied using implantable devices in patients with either major depression (MD) or epilepsy. Two earlier pilot ­studies[25,26] reported VNS evoked changes in PET CBF measures

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call